Trial intelligence / Profile preview

Sildenafil citrate in pre-eclampsia

NCT00141310Phase 2Terminated

Sponsor
Viatris
Start
Sep 2004
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, randomised, double-blind trial in preeclampsia comparing Sildenafil Citrate with Placebo (2 arms). Primary endpoint: Time from randomization to delivery. Started Sep 2004; status: terminated.

02

Drugs

sildenafil
03

Conditions

preeclampsia

Beyond the preview

Go deeper on NCT00141310.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00141310.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call